![3-[4-(2-Ethoxy-benzo-imidazol-1-ylmethyl)-biphenyl-2-yl]-4H-[1,2,4]oxadiazol-5-one chemical structure](/media/structures/SIAAGMHENOYLRE-UHFFFAOYSA-N.svg)
3-[4-(2-Ethoxy-benzo-imidazol-1-ylmethyl)-biphenyl-2-yl]-4H-[1,2,4]oxadiazol-5-one
- CAS
- 1857365-17-3
- Formula
- C24H20N4O3
- MW
- 412.4 g/mol
VQ-028931
Impurity reference standards
Azilsartan medoxomil impurities & reference standards
Characterised Azilsartan medoxomil impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
2reference materials
COAHPLC · NMR · MS on request
FAQs — Azilsartan medoxomil impurities
Which Azilsartan medoxomil impurities do you supply?
We list 2 Azilsartan medoxomil-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Azilsartan medoxomil impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Azilsartan medoxomil impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Azilsartan medoxomil impurity standards
We reply within one business day with price, pack options, lead time and documentation.